FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to preventive toxicology and prevention of occupational pathology, and can be used to reduce the harmful effects of lead oxide nanoparticles (PbO NP) on the nervous system of individuals, which are subjected to this effect in various production conditions at enterprises associated with extraction, processing and use of lead-containing components and ores. A method for increasing the body resistance to the neurotoxic action of lead oxide nanoparticles consists in the fact that the individuals of the risk group of such exposure take a bioprophylactic complex (BPC) in repeated 4-week courses 2 times a year. BPC is taken in doses providing daily production of: 100 mg of glycine, 600 mg of cysteine in metabolically active form of N-acetylcysteine, 4 g of glutamic acid, 25 ml of fish oil with 12-15% content of omega-3 polyunsaturated fatty acids with predominance of docosahexaenoic acid, not less than 45%, and eicosapentaenoic acid, not less than 40%, 50 mg of rutin, 5 g of pectin; as well as iodine, magnesium, calcium, vitamins A, group B – B1-B3, B5-B6, B9, B12, C, D3 and E in doses meeting the physiological needs of the body.
EFFECT: invention provides reducing the neurotoxic effect of lead oxide nanoparticles.
1 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INCREASE OF ORGANISM RESISTANCE TO COMBINED TOXIC ACTION OF NANOPARTICLES OF COPPER, ZINC AND LEAD OXIDES | 2017 |
|
RU2642674C1 |
| METHOD FOR INCREASING BODY RESISTANCE TO GENERAL TOXIC AND GENOTOXIC ACTION OF A COMBINATION OF ALUMINUM, TITANIUM AND SILICON OXIDE NANOPARTICLES | 2018 |
|
RU2694844C1 |
| METHOD FOR INCREASING RESISTANCE OF THE HUMAN BODY TO THE COMBINED CYTOTOXIC EFFECT OF SELENIUM AND COPPER OXIDE NANOPARTICLES | 2022 |
|
RU2786819C1 |
| METHOD OF INCREASING THE RESISTANCE OF THE BODY TO THE HARMFUL EFFECTS OF A TOXIC COMBINATION POLLUTING THE WORKSPACE AIR AND THE SURROUNDING ATMOSPHERE WITH RELATION TO THE ACTIVITIES OF BLISTER COPPER MANUFACTURE | 2021 |
|
RU2784169C1 |
| METHOD FOR INCREASING BODY RESISTANCE TO COMBINED HARMFUL EFFECT OF LEAD AND CADMIUM | 2019 |
|
RU2712954C1 |
| METHOD OF INCREASING BODY RESISTANCE TO CHRONIC COMBINED TOXIC EFFECT OF NANOPARTICLES OF NICKEL OXIDE AND MANGANESE OXIDE | 2015 |
|
RU2597157C1 |
| METHOD FOR PREVENTION OF ADVERSE HEALTH EFFECTS OF GENERAL TOXIC AND GENOTOXIC ACTION OF COPPER OXIDE NANOPARTICLES | 2014 |
|
RU2560682C1 |
| METHOD FOR INCREASING BODY RESISTANCE TO HARMFUL ACTION OF AMORPHOUS SILICON DIOXIDE NANOPARTICLES | 2020 |
|
RU2738565C1 |
| METHOD FOR PREVENTION OF ADVERSE EFFECT OF GENERAL TOXIC AND GENOTOXIC ACTION OF NANOSILVER ON HUMAN BODY | 2013 |
|
RU2530639C1 |
| METHOD OF PREVENTING AND CORRECTION OF DISTURBANCES OF MAIN FUNCTIONS OF CENTRAL NERVOUS SYSTEM IN CASE OF LEAD INTOXICATION IN PRENATAL AND EARLY POSTPARTUM PERIOD | 2009 |
|
RU2410107C1 |
